Lipitor-shilling drug maker Pfizer has announced that they will be buying rival Wyeth for $68 billion. [WSJ Health Blog]
Post a comment
Comments:
Pfizer put up this whole big research thing here in Ann Arbor, making them the biggest taxpayer the city had. 2,700 employees. January '07, they shuttered it. I guess their R&D budget wasn't high enough. So what were they doing, saving up to buy Wyeth?
note: I really have no idea what's going on with pfizer, and I don't care. I'll go on eating my high-cholesterol eggs and shrimp, not using Revolution on my cats, not taking Prozac to make myself numb, and this is such a troll at this point :(
@jaydez: They did lay off people, but that was to free up some money and prepare for the streamlining of the two companies. More people will be laid off as the merger continues as thats one of the points of the merger. Being able to do more with less people.
Also pfizer has nothing in their pipeline and their only big money maker - lipitor is loosing its patent soon. Thats why they needed to buy another drug company, so that they would have promising new drugs coming out soon. Also that is why they can let go of some of their research staff as they become redundant since Pfizer is taking in a whole new research department (and one that has been more successful).
@Tmoney02: Also Pfizer recently cut 10% of their workforce not just those 200 people, and just annouced their cutting another 10%.
@mantari: Well it did take getting 5 different banks to underwrite since noone would by themselves. This is on top of the huge amount of cash, stocks and revenue both companies have.







Headline: As auto sales decline, sales of boner pills are on the rise.